Your GP handed you a script. You're not sure you trust it. Here's the full picture — without the panic or the spin.

This is the conversation that happens in every GP clinic in the country. Bloods come back, cholesterol's up, your doctor mentions statins, and something in you resists. Maybe you've read that statins are overprescribed. Maybe a mate told you he got muscle pain and stopped. Maybe you just don't want to take a pill every day for something that doesn't make you feel sick.

All of that is reasonable. But the decision deserves better information than a gut feeling and a Facebook thread. So let's go through it properly.

Why Did Your Doctor Prescribe It?

Your GP isn't looking at your cholesterol number in isolation. They're calculating your absolute cardiovascular risk — the likelihood, as a percentage, that you'll have a heart attack or stroke within the next five years. That calculation factors in your age, sex, blood pressure, smoking status, diabetes, kidney function, and cholesterol levels.

If your risk is high enough — or if you already have established cardiovascular disease, familial hypercholesterolaemia, or diabetes with other risk factors — current Australian guidelines recommend the highest tolerated dose of a high-potency statin, regardless of your baseline cholesterol level. That's not because your GP is on Big Pharma's payroll. It's because every 1.0 mmol/L reduction in LDL cholesterol is associated with a 20% lower risk of major cardiovascular events. That's heart attacks, strokes, and cardiovascular deaths. The evidence base behind statins is one of the most robust in modern medicine — hundreds of thousands of participants across decades of randomised controlled trials.

How Statins Actually Work

LDL cholesterol — the "bad" kind — drives the formation of arterial plaques. Those plaques narrow your blood vessels, and when one ruptures, you get a clot. That clot in a coronary artery is a heart attack. In a cerebral artery, it's a stroke.

Statins block an enzyme called HMG-CoA reductase in the liver, which slows cholesterol production. Your liver compensates by pulling more LDL out of your bloodstream via LDL receptors. The net result: less LDL circulating, less plaque formation, lower risk of something catastrophic happening inside an artery. Statins also have anti-inflammatory and plaque-stabilising effects that go beyond the cholesterol number itself.

Can I Bring It Down Naturally?

Potentially — but it depends on where you're starting from and why your cholesterol is elevated.

Diet and exercise can meaningfully reduce LDL in some people. Reducing saturated fat, increasing soluble fibre, losing visceral fat, and regular aerobic exercise can lower LDL by roughly 10–15% in motivated individuals. That's meaningful if your levels are borderline and your overall cardiovascular risk is low.

But if your LDL is significantly elevated, or your risk profile includes diabetes, high blood pressure, family history, or existing vascular disease, a 10–15% reduction probably isn't going to get you to target. The 2025 Australian guideline now targets LDL below 1.4 mmol/L for people who've had an acute coronary event, with at least a 50% reduction from baseline. Lifestyle alone rarely delivers that kind of reduction — and for people with familial hypercholesterolaemia (a genetic condition that affects roughly 1 in 250 Australians), diet and exercise will barely scratch the surface.

This isn't your GP dismissing lifestyle. It's your GP acknowledging that for your specific risk level, lifestyle alone isn't enough. The two aren't mutually exclusive — the best outcomes come from statins plus lifestyle changes, not one or the other.

What If I Don't Want Statins? The Alternatives

If you genuinely can't tolerate statins — and true intolerance is less common than people think — there are other options.

Ezetimibe blocks cholesterol absorption in the gut. It moderately lowers LDL by 15–25% and is often used in combination with a statin for additive effect. NCBI It's well-tolerated, inexpensive, and PBS-listed. For people who can't manage full-dose statins, a low-dose statin plus ezetimibe can sometimes achieve similar LDL reductions with fewer side effects.

Fenofibrate primarily targets triglycerides rather than LDL, so it's not a direct statin substitute. But for blokes with the classic metabolic pattern — high triglycerides, low HDL, central obesity — it has a role, sometimes alongside a statin.

PCSK9 inhibitors are the heavy hitters. Evolocumab (Repatha) is a monoclonal antibody given by self-injection every two to four weeks. PCSK9 inhibitors reduce LDL by 50–60% — a massive reduction, but they're reserved for people at very high risk who can't reach target on statins plus ezetimibe. Both evolocumab and alirocumab are PBS-subsidised in Australia for patients with familial or non-familial hypercholesterolaemia at high cardiovascular risk but the eligibility criteria are strict.

Inclisiran (Leqvio) is the newest option — a "gene silencer" that acts directly in the liver to reduce PCSK9 production, lowering cholesterol by about half. It's now PBS-listed in Australia and only requires injection twice a year after the initial loading doses Thelimbic — a genuine game-changer for adherence. Without PBS subsidy, it would cost patients over $4,000 per year.

All of these alternatives are evidence-based. None of them are first-line for a reason — statins remain the most studied, most effective, and cheapest option for the majority of people.

Do Natural Supplements Work?

Red yeast rice, bergamot, plant sterols, fish oil — the supplement aisle is full of cholesterol-lowering promises. Here's the honest assessment.

Plant sterols (found in some fortified spreads and yoghurts) can reduce LDL by about 5–10%. Red yeast rice contains a naturally occurring statin compound (monacolin K, which is chemically identical to lovastatin), so it can work — but the dose varies wildly between products, it's unregulated, and you're essentially taking a poorly controlled statin while telling yourself you're not taking statins.

Fish oil primarily affects triglycerides, not LDL. Bergamot has limited and inconsistent evidence. Coenzyme Q10 may help with statin-related muscle symptoms but doesn't lower cholesterol.

The fundamental problem: none of these have the hard endpoint data that statins have. No randomised controlled trial has shown that any supplement reduces heart attacks, strokes, or cardiovascular deaths. If your risk is low and your LDL is mildly elevated, supplements and lifestyle might be a reasonable first step. If your risk is moderate to high, you're bringing a butter knife to a gunfight.

What Happens If I Just Don't Take It?

Nothing — in the short term. That's the insidious part. High cholesterol doesn't hurt. There's no symptom. You feel completely normal right up until the moment you don't.

Cardiovascular disease is the leading cause of death in Australian men. It kills more blokes than cancer. And the blokes who present with a first heart attack in their 50s almost always had years of unmanaged risk factors — including high LDL — that could have been treated.

Nobody can make you take a medication. But declining a statin when your risk profile warrants one is a bet that your arteries will stay clear despite the evidence suggesting otherwise. It's your right to make that bet. Just make sure you're making it with open eyes, not because someone on a podcast told you cholesterol is a myth.

The "Big Pharma" Question

Let's address it directly, because it's the elephant in the room.

Yes, pharmaceutical companies make money from statins — though the blockbuster patents expired years ago and most statins are now dirt-cheap generics manufactured by dozens of companies worldwide. Atorvastatin costs the PBS a few dollars per script. Nobody is getting rich off your rosuvastatin prescription.

The evidence for statins wasn't produced by a single company. It comes from independent academic trials, government-funded research, and meta-analyses conducted by groups like the Cholesterol Treatment Trialists' (CTT) Collaboration at Oxford, which pooled individual participant data from 26 randomised trials involving 170,000 people. You can argue with a company's marketing. You can't easily argue with 170,000 data points.

Does pharma influence medicine? Absolutely — and healthy scepticism is warranted, particularly around newer, expensive medications. But applying that scepticism selectively to statins (one of the cheapest, most studied drug classes in existence) while happily taking unregulated supplements with zero outcome data is exactly the kind of inconsistency worth examining.

The Two-Minute Version

Your GP prescribed statins because your cardiovascular risk warrants it — not because of your cholesterol number alone, but because of your overall risk of a heart attack or stroke. Diet and exercise help, but for moderate-to-high risk individuals, they're usually not enough on their own. Alternatives exist — ezetimibe, PCSK9 inhibitors, inclisiran — but statins remain first-line because they're effective, safe, cheap, and backed by more evidence than almost any other drug class.

Supplements aren't a substitute. The risks of declining treatment are real but invisible until they're not. And the Big Pharma argument doesn't hold up when the drug in question is a generic that costs less than your morning coffee.

Talk to your GP. Ask about your absolute risk score. Understand the numbers. Then make an informed decision.